AMRN vs GILD · rev $87.3M vs P/E 18, rev $7.80B
Amarin Corporation PLC (AMRN) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Amarin Corporation PLC (AMRN) is a drug manufacturers - general company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AMRN revenue for 2026-06-30 was $87.3M. Net income was -$18.2M. Revenue was up 93.5% from 2026-03-31 to 2026-06-30. AMRN currently screens at market cap $292.1M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AMRN currently screens at market cap $292.1M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AMRN and GILD stock pages for the full models.
Not investment advice.